Aditya Kandoi is a visionary healthcare entrepreneur leading Redcliffe Labs, India’s fastest-growing omnichannel diagnostics network. With a mission to ‘Give India its Right to Quality Diagnostics,’ he has built an organization that combines cutting-edge medical technology with awareness, affordability, accessibility, and accuracy. Under his leadership, Redcliffe Labs has already impacted 7 million+ lives and aims to serve 100 million+ Indians in the next five years.

Aditya’s journey began in the corporate world, where he gained deep expertise in investment banking, consulting, and big data analytics. He held key positions at Deloitte, JP Morgan, American Express, and Barclays, before pivoting to healthcare entrepreneurship in 2015. His third healthcare venture, Redcliffe Labs, founded in 2021, has rapidly scaled to become a market disruptor.

An alarming reality drove the foundation of Redcliffe Labs—2 out of 3 Indians could be saved with timely medical intervention, yet the gap between early diagnosis and accessible healthcare was widening. Life-saving interventions were becoming a privilege rather than a right, highlighting the urgent need for affordable, high-quality diagnostics. Recognizing this crisis, Aditya launched Redcliffe Labs as a purpose-driven effort to bridge this gap.

Today, it operates with 80+ labs, 2000+ collection centers across 220+ cities, 1000+ phlebotomists, and a workforce of over 2500 employees. The company has raised $100M+ across multiple funding rounds and is on track for EBITDA profitability in FY24-25.